在目前动荡的股市环境中，许多投资者不禁会问，股东减持的原因是什么？奥精医疗的情况尤为引人注目。根据近日的公告，股东BioVeda China RMB Investment, Limited计划在2025年间减持135.55万股，套现金额约2312.51万元。这一决策引发了广泛的关注。我们来看看，这背后可能隐藏了哪些信息。 首先，让我们来了解一下奥精医疗这家公司。成立于2004年，以研发和销售高端生 ...

在当今医疗行业发展日新月异的时代，您是否关注到了奥精医疗股东BioVeda China RMB Investment, ...

1月23日，奥精医疗公告，股东BioVeda China RMB Investment,Limited计划在2025年2月25日至2025年5月25日期间，通过大宗交易或竞价交易方式减持不超过135.55万股 ...

e公司讯，奥精医疗(688613)1月23日晚间公告，公司持股5.6%的股东BioVeda China RMB Investment Limited（简称“BioVeda”）因根据自身资金安排，拟通过集中竞价、大宗交易方式减持公司股份不超过135.55万股，占公司总股份的1%。

China is now a major trade partner to more than 150 countries and regions. Data from the General Administration of Customs show imports and exports reached 43.85 trillion RMB in 2024, increasing by ...

China’s role as a global investor continues to expand. According to data from China’s Ministry of Commerce (MOFCOM) and the State Administration of Foreign Exchange (SAFE), in 2024, China’s total ...

The majority 80 percent of such cross-border RMB settlements concluded in Shanghai last year were to serve cross-border financing and investment as well as securities trading. This has helped ...

Rand Merchant Bank (RMB) has once again been recognised as one of South Africa’s Top Employers by the Top Employers Institute ...